Dissertation > Excellent graduate degree dissertation topics show

N-acteyl-β-D-glucosaminidase Assay Kit and Its Clinical Application

Author: XuXiuFen
Tutor: LiHong
School: Zhejiang University
Course: Diabetes and its complications
Keywords: N-acetyl-β-D-glucosaminidase assay kit diabetic nephropathy
CLC: R587.1
Type: Master's thesis
Year: 2011
Downloads: 38
Quote: 0
Read: Download Dissertation

Abstract


1 N-acteyl-β-D-glucosaminidase (NAG) assay kit PreparationAim:To prepare liquid NAG assay kit for clinical testing.Methods:Use VRA-NAG as substrate, select appropriate buffer system, concentration of substrate, and surface active agent, preparation Liquid NAG assay kit and evaluated its linearity, precision, accuracy, stability and anti-jamming and other properties.Results:NAG activity is maximum in 100 mmol/L pH 5.8 citric acid buffer, there is little difference between pH 5.0-6.6, and taking into accout of the stability of the substrate, we choose pH 5.0 as the best value of NAG determination. According to Michaelis-Menten equation, Km value is 0.32 mmol/L, therefore, We choose 10 times of the Km value 3.2 mmol/L as the best substrate concentration of the NAG assay kit. Add 0.1% Tween 20 and 0.1% BSA to substrate solution helps VRA-NAG to dissolve and maintain it stability. NAG activity of 0-360 U/L range is in good linearity. Intraassay CV of low sample is 1.74%, while high sample is 0.86%; between CV of low sample is 3.21%, median sample is 1.65% and high sample is 1.08%. The average recovery was 103.7%. Reagent stays stability if opened for 7 days or kept for one year. The concentration of vitamin C<50 mg/L not interfere the assay, while a higher concentration will cause negative interference. Lactate<0.9 g/L,pyruvate <20 mg/L. tartaric acid<17 mg/L, uric acid <0.13 g/L, glucose <9g/L, bilirubin <4.6 mg/L show no significant effect on measurement.Conclusion:This study developed a liquid NAG assay kit which can sensitively. accurately and fastly measure NAG activity in human urine. The linearity, sensitivity,precision, stability and anti-interference performance of the NAG assay kit meet the requirements of clinical application.2 Clinical application of NAG kit in the diagnosis of diabetic nephropathyObjective:To study the application of urinary NAG in the diagnosis of diabetic nephropathy.Methods:Assay the NAG activity of diabetic patients without nephropathy group, diabetic nephropathy group and the control group,Results:The NAG value of diabetic patients without nephropathy is 20.5±16.6 U/L, diabetes nephropathy group is 40.6±13.4 U/L, while control group is 7.2±2.8 U/L. There are significant difference in NAG concentration of diabetic patients without nephropathy, and diabetes nephropathy, compared with control group (P<0.05). There are significant difference in NAG concentration of diabetes nephropathy compared with diabetic patients without nephropathy (P<0.05).Conclusion:Urinary NAG detection play a certain part in the diagnosis of the renal damage in early diabetes.Summary1. NAG assay kit can sensitively, accurately and fastly measure NAG activity in human urine.2. The linearity, sensitivity, precision, stability and anti-interference performance of the NAG assay kit meet the requirements of clinical application.3. The preliminary clinical testing proved that NAG assay kit can sensitively and accurately measure NAG activity, which might be a sensitive early indicator of diabetic nephropathy.

Related Dissertations

  1. Low Dose of Spironolactone Reduces Oxidative Stress and Prevents the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus,R587.2
  2. Human adipose -derived mesenchymal stem cells to treat diabetic nephropathy rat studies,R692
  3. The Changes of T Lymphocyte Subsets and Costimulatory Molecules Before and After Shuxuetong Treatment in Type 2 Diabetes Subjects with Diabetic Kidney Disease,R692
  4. The Expression of Angiopoietin-2 in Diabetic Nephropathy and Correlated with Proteinuria,R587.2
  5. Pentamethylquercetin on diabetic nephropathy in rats and its mechanism,R285.5
  6. Analysis of the Relationship between the Expression of SARA and the Pathological Types and Clinical Phenotypes of Diabetic Nephropathy,R587.2
  7. RAS dysfunction induced by high glucose in renal tubular epithelial cells and its mechanism of action,R692.9
  8. Effect of Blood Glucose Fluctuation on Renal Pathological Change and Collagen Ⅳ Expression of Diabetic Rats,R587.1
  9. Effects of Pioglitazone on Serum Osteopontin and Urinary Microalbuminuria in the Type 2 Diabetic Patients with Diabetic Nephropathy,R587.2
  10. Serum 25-hydroxy Vitamin D Level in Diabetic Patients and Its Effect on Blood Glucose and Bone Mass,R587.1
  11. Study on the Effects of the Mothod of Invigorating the Spleen and Kidney Detoxification and Vigoration of Blood Circulation on Early Diabetic Nephropathy and Flt-1 Expression on Rat Models,R259
  12. TCM retention enema treatment of diabetic nephropathy,R259
  13. The Change of Serum Fibroblast Growth Factor-23 Level and Its Significance to Vascular Calcification in Chronic Kidney Disease Stage 5 Patients with Diabetic Nephropathy,R692.5
  14. Serum concentrations of P-selectin gene polymorphism and diabetic nephropathy study,R587.2
  15. The Association between Pigment Epithelium-Derived Factor and Urinary Albumin Excretion Rate in Type 2 Diabetes Mellitus,R587.1
  16. Diagnostic Signifcance of Assay of Serum Retinal-Binding Protein in Early Diabetic Nephropathy,R587.2
  17. SDF-1α and its receptor expression in the kidney of diabetic rats and the effect of,R587.1
  18. Diabetic nephropathy in patients with type 2 diabetes and diabetic retinopathy study,R587.2
  19. The Role of p38MAPK on High-glucose Induced ICAM-1 and VCAM-1 Expression in Mesangial Cell,R587.2
  20. Diabetic nephropathy fatty acid metabolism studies,R587.2

CLC: > Medicine, health > Internal Medicine > Endocrine diseases and metabolic diseases > Islet disease > Diabetes
© 2012 www.DissertationTopic.Net  Mobile